0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita]

100 MG/ML · Prefilled Syringe · injection

A form of adalimumab-atto →

0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita] — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.

0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe [Amjevita]

Active ingredient

adalimumab-atto →

Classification

Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker

Drug interactions

Adalimumab-atto has several drug interactions that may increase the risk of serious infections or require monitoring of concomitant medications.

  • majorabatacept — Increased risk of serious infection.
  • majoranakinra — Increased risk of serious infection.
  • majorlive vaccines — Avoid use with AMJEVITA.
  • moderateCYP450 substrates — Monitoring of the effect or drug concentration may be required.

Real-world adverse events (FAERS)

Device Difficult to Use351Product Storage Error280Drug Dose Omission By Device229Circumstance or Information Capable of Leading to Medication Error194Accidental Exposure to Product135Injection Site Pain109Wrong Technique in Product Usage Process78Intercepted Product Administration Error75

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →